The Role of Occupational Therapy for Improving Medication Management for Persons With AMD, DR and Glaucoma

Trial statusRecruiting
Trial phaseEarly Phase 1
Trial typeInterventional
Biological sexAll
Age50-100
SponsorMCPHS University

About this trial

The goal of this clinical trial is to learn if education about additional task lighting, enhanced contrast, enlarged print instructions, smart apps and organizational strategies will improve medication management skills. The main questions it aims to answer are:

Does additional task lighting, enhanced contrast, enlarged print instructions, smart apps and organizational strategies improve medication management skills, reduce errors and improve functional use of remaining vision for this task?

Participants will:

Oftentimes, the client is unaware of these strategies which may improve occupational performance during a valued activity. Clients with AMD, DR or Glaucoma who choose to receive the one hour OT service will be provided with 1:1 education regarding the devices and strategies that may improve their ability to perform medication management skills.

Eligibility criteria

This trial accepts healthy volunteers

Qualifiers

Clients with AMD, DR or Glaucoma

Clients who choose to participate will allow their deidentified data to be evaluated for outcomes.

Disqualifiers

Clients with other age related eye diseases other than AMD, DR or Glaucoma.

Clients who do not wish to participate in this study.

Trial design

Design model

Single group

Treatments tested in this trial

  • occupational therapy interventions for low vision care

    Combination product

    Occupational therapists utilize many different treatment strategies when caring for the client with low vision. Oftentimes, the client is unaware of these strategies which may improve occupational performance during a valued activity. Interventions include task lighting, organizational strategies, smart apps, contrast, enlarged print, typoscopes and electronic magnification devices.

Treatment groups

50 Participants
are divided into 1 treatment group
Group A: Receiving OT interventionsExperimental treatment 1 intervention

Trial outcomes

Primary outcomes

1

Revised Self Report Assessment of Functional Visual

A standardized assessment which provides information on how well adults with vision loss can perform daily tasks. This tool has 33 assessment components and a higher score indicates less functional impairment. A lower score indicates a higher impairment.

Time frame
Results from the Revised-Self-Report Assessment of Functional Visual Performance assessment will be determined on day 1 and 4 weeks later
2

MediCog Screening Tool

The Medi-Cog has a maximum score of 10 points, and a score of 7 or lower may indicate cognitive impairment.

Time frame
Results from the MediCog will be determined on day 1 and will be obtained 4 weeks later

Secondary outcomes

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.